Comment on FR Doc # 2026-09930

I respectfully and strongly urge the DEA to deny Benuvia Operations, LLC.'s application to manufacture mescaline, as well as any similar applications. Before expanding commercial mescaline production, the DEA should demonstrate that it has adequate safeguards to protect Peyote (and the natural habitat it grows on) and the Native and Indigenous communities for whom it is a sacred medicine, as well as the consumer. Many Native leaders and organizations have expressed concerns that existing protections are insufficient to prevent the illegal harvesting, theft, or diversion of Peyote from wild populations, and there has been no solid research on the impact of authorizing companies like this to profit from mescaline production, regardless of the source and lack of proven safety. There has also been insufficient transparency regarding how synthetic mescaline would be manufactured (where did it come from) and what oversight would ensure that its production does not negatively impact Peyote conservation or Native traditional practices. Synthetic is not the answer to healing. It is also concerning that there are no transparent standards ensuring the lawful and ethical sourcing and use of mescaline, meaningful tribal consultation regarding Peyote and related sacred medicines such as wachuma (San Pedro), or policies that prioritize and protect Native traditional religious and medicinal practices. Until these concerns are fully addressed through meaningful consultation with affected Tribes and enforceable conservation measures, I urge the DEA to deny this application. See attached file.